Atlas Trials

SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations

Clinical trial NCT02940990 · UNKNOWN

Trial details

NCT number
NCT02940990
Sponsor
Shanghai Chest Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLCSBRTGM-CSF
Start date
2016-11-01
Primary completion
2019-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.